2028年までの北米皮膚がん診断市場予測 – 新型コロナウイルス感染症の影響とタイプ別(黒色腫および非黒色腫)およびスクリーニングタイプ別(血液検査、皮膚鏡検査、画像検査、リンパ節生検、皮膚生検)地域分析

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 107    |    Report Code: TIPRE00029075    |    Category: Life Sciences

North America Skin Cancer Diagnostics Market

北米の皮膚がん診断市場は、2021 年の 14 億 2,300 万米ドルから 2028 年までに 23 億 5,420 万米ドルに達すると予想されています。 2021 年から 2028 年にかけて 7.5% の CAGR で成長すると推定されています。

 

乳房、肺、結腸、直腸、前立腺がん、皮膚がん、胃がんがこの地域では非常に多かったです。 WHOのデータによると、2020年に報告された新規症例のうち約120万人が皮膚がんでした。皮膚がんは、すべてのがんの種類の中で最も一般的です。黒色腫と非黒色腫は 2 種類の皮膚がんです。黒色腫は皮膚がんの全症例の約 1% を占めますが、皮膚がんによる死亡の最大の原因は黒色腫です。黒色腫の発生率は過去数十年で急速に増加しており、年齢によっても変化します。米国癌協会によると、米国の年間新規癌診断数は 2022 年に約 99,780 件に達する可能性があります。このうち、57,180 人の患者は男性である可能性が高く、42,600 人は女性であると考えられます。さらに、7,650人(男性5,080人、女性2,570人)が黒色腫により死亡すると予想されていると述べています。皮膚がん財団によると、2012 年から 2022 年にかけて、浸潤性黒色腫の年間診断数は 31% 増加しました。したがって、皮膚がんの発生率は今後数年間で増加する可能性があり、その結果、皮膚がん診断に対する需要が高まると考えられます。

 

機能やテクノロジーを活用することで、ベンダーは新しい顧客を引き付け、新興市場での拠点を拡大します。この要因が、有望な CAGR で皮膚がん診断市場の成長を推進しています。

 

北米の皮膚がん診断市場の収益と 2028 年までの予測 (百万米ドル)

皮膚がん診断市場は次のように分類されます。タイプとスクリーニングタイプ。種類に基づいて、市場は黒色腫と非黒色腫に分類されます。スクリーニングの種類に基づいて、市場は皮膚生検、皮膚鏡検査、リンパ節生検、画像検査、血液検査に分類されます。国に基づいて、市場は米国、カナダ、メキシコに分類されます。

 

SkylineDx BV; AMLo バイオサイエンス リミテッド;ダームライトLLC;ビオメリューSA;ベリスキン株式会社;キャッスルバイオサイエンス社;ダームテック株式会社; F. ホフマン・ラ・ロシュ社;        および Michelson Diagnostics Ltd. は、北米の皮膚がん診断市場の大手企業の 1 つです。          

 

North America Skin Cancer Diagnostics Strategic Insights

Strategic insights for North America Skin Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-skin-cancer-diagnostics-market-strategic-framework.webp
Get more information on this report

North America Skin Cancer Diagnostics Report Scope

Report Attribute Details
Market size in 2021 US$ 1,423.0 Million
Market Size by 2028 US$ 2,354.2 Million
Global CAGR (2021 - 2028) 7.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By タイプ
  • 黒色腫と非黒色腫
By 検査の種類
  • 血液検査
  • 皮膚鏡検査
  • 画像検査
  • リンパ節生検
  • 皮膚生検
Regions and Countries Covered 北米
  • 米国
  • カナダ
  • メキシコ
Market leaders and key company profiles
  • SkylineDx BV
  • AMLo Biosciences Limited
  • DermLite LLC
  • F. HOFFMANN-LA ROCHE LTD
  • bioMerieux SA
  • Veriskin Inc.
  • Castle Biosciences, Inc.
  • DermTech Inc
  • ACS Dobfar S.p.A
  • Michelson Diagnostics Ltd.
  • Get more information on this report

    North America Skin Cancer Diagnostics Regional Insights

    The regional scope of North America Skin Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-skin-cancer-diagnostics-market-geography.webp
    Get more information on this report

    The List of Companies - North America Skin Cancer Diagnostics Market

    1. SkylineDx BV
    2. AMLo Biosciences Limited
    3. DermLite LLC
    4. F. HOFFMANN-LA ROCHE LTD
    5. bioMerieux SA
    6. Veriskin Inc.
    7. Castle Biosciences, Inc.
    8. DermTech Inc  
    9. ACS Dobfar S.p.A
    10. Michelson Diagnostics Ltd.                   
    Frequently Asked Questions
    How big is the North America Skin Cancer Diagnostics Market?

    The North America Skin Cancer Diagnostics Market is valued at US$ 1,423.0 Million in 2021, it is projected to reach US$ 2,354.2 Million by 2028.

    What is the CAGR for North America Skin Cancer Diagnostics Market by (2021 - 2028)?

    As per our report North America Skin Cancer Diagnostics Market, the market size is valued at US$ 1,423.0 Million in 2021, projecting it to reach US$ 2,354.2 Million by 2028. This translates to a CAGR of approximately 7.5% during the forecast period.

    What segments are covered in this report?

    The North America Skin Cancer Diagnostics Market report typically cover these key segments-

  • タイプ (黒色腫と非黒色腫)
  • 検査の種類 (血液検査, 皮膚鏡検査, 画像検査, リンパ節生検, 皮膚生検)
  • What is the historic period, base year, and forecast period taken for North America Skin Cancer Diagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Skin Cancer Diagnostics Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in North America Skin Cancer Diagnostics Market?

    The North America Skin Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • SkylineDx BV
  • AMLo Biosciences Limited
  • DermLite LLC
  • F. HOFFMANN-LA ROCHE LTD
  • bioMerieux SA
  • Veriskin Inc.
  • Castle Biosciences, Inc.
  • DermTech Inc
  • ACS Dobfar S.p.A
  • Michelson Diagnostics Ltd.
  • Who should buy this report?

    The North America Skin Cancer Diagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Skin Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.